Correction: UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease.

Autor: Rizq O; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Department of Hematology, Chiba University Hospital, Chiba, Japan.; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Mimura N; Department of Hematology, Chiba University Hospital, Chiba, Japan. naoyamimura@chiba-u.jp.; Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan. naoyamimura@chiba-u.jp., Oshima M; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan., Momose S; Department of Pathology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan., Takayama N; Department of Regenerative Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan., Itokawa N; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Koide S; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Shibamiya A; Department of Hematology, Chiba University Hospital, Chiba, Japan., Miyamoto-Nagai Y; Department of Hematology, Chiba University Hospital, Chiba, Japan., Rizk M; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan., Nakajima-Takagi Y; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan., Aoyama K; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan., Wang C; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; The State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, School of Life Sciences, Inner Mongolia University, Hohhot, China., Saraya A; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan., Ito R; Central Institute for Experimental Animals, Kanagawa, Japan., Seimiya M; Department of Medical Technology and Sciences, School of Health Sciences at Narita, International University of Health and Welfare, Narita, Japan., Watanabe M; Department of Clinical Laboratory, Chiba University Hospital, Chiba, Japan., Yamasaki S; Laboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Shibata T; Laboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Yamaguchi K; Division of Clinical Genome Research, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Furukawa Y; Division of Clinical Genome Research, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Chiba T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan., Sakaida E; Department of Hematology, Chiba University Hospital, Chiba, Japan.; Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan., Nakaseko C; Department of Hematology, International University of Health and Welfare, Narita, Japan., Tamaru JI; Department of Pathology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan., Tai YT; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Anderson KC; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Honda H; Field of Human Disease Models, Major in Advanced Life Sciences and Medicine, Institute of Laboratory Animals, Tokyo Women's Medical University, Tokyo, Japan., Iwama A; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. 03aiwama@ims.u-tokyo.ac.jp.; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan. 03aiwama@ims.u-tokyo.ac.jp.; Laboratoty of Cellular and Molecular Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan. 03aiwama@ims.u-tokyo.ac.jp.
Jazyk: angličtina
Zdroj: Leukemia [Leukemia] 2023 Sep; Vol. 37 (9), pp. 1952.
DOI: 10.1038/s41375-023-01969-y
Databáze: MEDLINE